Featured,Shroom News PharmaTher Commences Phase 2 Clinical Trial for Treatment of Parkinson’s Disease By Dennis Mutua October 07, 2021 Clinical stage biotechnology company focusing on research, development and commercialization of psychedelic pharmaceuticals PharmaTher Holdings Ltd. (CSE: PHRM) (OTCQB: PHRRF) says that it has started phase 2 KET-LID clinical tria...
Psychedelic Stocks,Shroom News MindMed Enters Into Research Collaboration Agreement With Sphere Health By Dennis Mutua October 06, 2021 Psychedelic medicine biotechnology company developing psychedelic inspired medicine and therapies to treat addictions and mental health conditions MindMed Inc. (NASDAQ: MNMD) (NEO: MMED) announced having entered into a strategic r...
Spotlight Stock,Trends & Articles Lobe Sciences and the World Boxing Association Enter Into a Partnership Targeting PTSD and mTBI By Dennis Mutua October 06, 2021 Life sciences company specializing in research and development of psychedelic medicines Lobe Sciences Ltd. (CSE: LOBE) (OTCMKTS: GTSIF) announced having entered into a partnership with the World Boxing Association (WBA) to launch ...
Featured,Trends & Articles Seattle City Votes in Favor of a Proposal to Decriminalize Psychedelics By Dennis Mutua October 05, 2021 The City Council of Seattle has voted in favor of a proposal seeking to decriminalize possession and use of psychedelics in the city. Seattle becomes the latest entry in a list of United States cities which have taken such a move....
Psychedelic Stocks,Shroom News Delix Therapeutics Raises $70 Million in Latest Financing Round By Dennis Mutua October 04, 2021 Neuroscience company focused on modern tools of pharmaceutical development to some of nature’s most ancient therapies like psychedelics Delix Therapeutics announced having raised $70 million from its latest Series A financing ro...
Spotlight Stock,Trends & Articles Mind Cure Health Officially Starts Trading on the OTCQX Best Market By Dennis Mutua October 01, 2021 Mental health and wellness company merging psychedelic research, medicines and technology to come up with treatments for mental health patients Mind Cure Health Inc. (CSE: MCUR) (OTCQX: MCURF) announced having commenced trading on...
Psychedelic Stocks,Shroom News Billionaire Elon Musk Acknowledges the Healing Potential of Psychedelics Drugs By Dennis Mutua October 01, 2021 Elon Musk, founder and chief executive officer of leading electric vehicle manufacturer Tesla Inc. (TSLA) has acknowledged that psychedelics drugs carry with them a huge therapeutic potential. Musk made these sentiments during a q...
Spotlight Stock,Trends & Articles Texas Commences Research on Psychedelics Treatments For PTSD By Dennis Mutua September 30, 2021 Texas State has officially initiated clinical studies to find out the effects of active compounds in psychedelics such as psilocybin in the treatment of post-traumatic stress disorder (PTSD). The clinical studies have been auth...